HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Minor, P. D. Articles by Hovi, T. Search for Related Content PubMed PubMed Citation Articles by Minor, P. D. Articles by Hovi, T. Agricola Articles by Minor, P. D. Articles by Hovi, T.

Conservation in vivo of Protease Cleavage Sites in Antigenic Sites of Poliovirus

¹ National Institute for Biological Standards and Control, Holly Hill, Hampstead, London NW3 6RB, U.K.
and² Enterovirus Laboratory, Department of Virology, National Public Health Institute, Helsinki, Finland

Polioviruses possess three major antigenic sites which have been located chemically and structurally on the particle. One of these sites, designated site 1, is strongly immunodominant for serotype 3, but highly immunorecessive for type 1. We report that monoclonal antibodies directed against site 1 of type 1 poliovirus may be isolated by an altered route of immunization of the donor mice. Site 1 is shown to be highly variable for type 1, but highly conserved for type 3 poliovirus, although the converse would be predicted from their immunodominance. The evidence presented suggests that the antigenic conservation is associated with a strong selective pressure for a proteolytic cleavage site within site 1 of type 3. As proteolytic cleavage results in the loss of the antigenicity of site 1 the presence of the cleavage site in a virus replicating in the gut in the presence of proteases would protect the virus from neutralizing antibodies directed against uncleaved site 1. The conservation of the site in type 3 is thus consistent with the view that site 1 is a significant target of a human as well as a murine immune response against type 3.

Keywords: poliovirus, protease cleavage, antigenic sites

Received 5 February 1987; accepted 18 March 1987.

This article has been cited by other articles:

				J. Martín, G. Dunn, R. Hull, V. Patel, and P. D. Minor Evolution of the Sabin Strain of Type 3 Poliovirus in an Immunodeficient Patient during the Entire 637-Day Period of Virus Excretion J. Virol., April 1, 2000; 74(7): 3001 - 3010. [Abstract] [Full Text]

				L. M. Shulman, R. Handsher, C.-F. Yang, S.-J. Yang, J. Manor, A. Vonsover, Z. Grossman, M. Pallansch, E. Mendelson, and O. M. Kew Resolution of the Pathways of Poliovirus Type 1 Transmission during an Outbreak J. Clin. Microbiol., March 1, 2000; 38(3): 945 - 952. [Abstract] [Full Text]

				O. M. Kew, R. W. Sutter, B. K. Nottay, M. J. McDonough, D. R. Prevots, L. Quick, and M. A. Pallansch Prolonged Replication of a Type 1 Vaccine-Derived Poliovirus in an Immunodeficient Patient J. Clin. Microbiol., October 1, 1998; 36(10): 2893 - 2899. [Abstract] [Full Text]